52w high/low | ₹3134 / ₹1630 |
P/E ratio | 65.22 |
Dividend | 0.25 |
ROE | 9.73 |
ROCE | 9.29 |
Face value | 10 |
Book value | ₹382.47Cr |
Market capital | ₹2,065.47Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Incorporated as a private limited company in Apr. '87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov. '93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun.